FEB 27, 2015 9:28 AM PST

Almost 500K in US Suffered from C. diff Infections in Single Year

WRITTEN BY: Judy O'Rourke
Clostridium difficile (C. difficile, or C. diff) caused almost half a million infections among patients in the United States in a single year, according to a study released by the Centers for Disease Control and Prevention (CDC).

Some 29,000 patients died within 30 days of the initial diagnosis of C. difficile. Of those, about 15,000 deaths were estimated to be directly attributable to C. difficile infections, making C. difficile a very important cause of infectious disease death in the United States. More than 80 percent of the deaths associated with C. difficile occurred among Americans aged 65 years or older. C. difficile causes an inflammation of the colon and deadly diarrhea.
C. difficile
Previous studies indicate that C. difficile has become the most common microbial cause of healthcare-associated infections in US hospitals and costs up to $4.8 billion each year in excess health care costs for acute care facilities alone. The new study found that one out of every five patients with a healthcare-associated C. difficile infection experienced a recurrence of the infection and one out of every nine patients aged 65 or older with a healthcare-associated C. difficile infection died within 30 days of diagnosis.

"C. difficile infections cause immense suffering and death for thousands of Americans each year," says Tom Frieden, MD, MPH, the CDCs director. "These infections can be prevented by improving antibiotic prescribing and by improving infection control in the health care system. CDC hopes to ramp up prevention of this deadly infection by supporting State Antibiotic Resistance Prevention Programs in all 50 states."

Patients who take antibiotics are most at risk for developing C. difficile infections. More than half of all hospitalized patients will get an antibiotic at some point during their hospital stay, but studies have shown that 30 percent to 50 percent of antibiotics prescribed in hospitals are unnecessary or incorrect. When a person takes broad-spectrum antibiotics, beneficial bacteria that are normally present in the human gut and protect against infection can be suppressed for several weeks to months. During this time, patients can get sick from C. difficile picked up from contaminated surfaces or spread person to person. Unnecessary antibiotic use and poor infection control may increase the spread of C. difficile within a facility and from facility to facility when infected patients transfer, such as from a hospital to a nursing home.

Older Americans are especially vulnerable to this deadly diarrheal infection. The CDC study found that one out of every three C. difficile infections occurs in patients 65 years or older and two out of every three healthcare-associated C. difficile infections occur in patients 65 years or older. More than 100,000 C. difficile infections develop among residents of US nursing homes each year. Women and Caucasian people are at increased risk of C. difficile infection.

About two-thirds of the C. difficile infections were found to be associated with an inpatient stay in a health care facility, but only 24 percent of the total cases occurred among patients while they were hospitalized. Almost as many cases occurred in nursing homes as in hospitals, and the remainder of the healthcare-associated cases occurred among patients who were recently discharged from a health care facility.

Although more than 150,000 of the half a million infections in the new study were community-associated and thus had no documented inpatient health care exposure, a separate recent CDC study found that 82 percent of patients with community-associated C. difficile infections reported exposure to outpatient health care settings such as physician's or dentist's offices in the 12 weeks before their diagnosis; this finding underscores the need for improved antibiotic use and infection control in these settings as well. It is estimated that more than 50 percent of antibiotics are prescribed unnecessarily in outpatient settings for upper respiratory infections like cough and cold illness, most of which are caused by viruses.

Another recent CDC study showed that a 30 percent decrease in the use of antibiotics linked to C. difficile infections in hospitals could reduce the deadly infections by more than 25 percent in hospitalized and recently discharged patients. A new retrospective study from a Canadian hospital found that a 10 percent decrease in overall antibiotic use across different wards was associated with a 34 percent decrease in C. difficile infections. A third CDC study among patients without a recent hospitalization or nursing home stay (ie, community-associated cases) found that a 10 percent reduction in the use of all antibiotics in outpatient settings could reduce C. difficile infections by 16 percent. In England in recent years, the number of C. difficile infections has been reduced by well over 60 percent, largely due to improvements in antibiotic prescribing.

To help hospitals develop antibiotic prescribing improvement programs ("antibiotic stewardship" programs), CDC has developed several tools, and the agency is also working with states to improve outpatient prescribing and implement stewardship across the continuum of care. The Agency for Healthcare Research and Quality (AHRQ) has developed a toolkit to help hospitals implement antibiotic stewardship programs to reduce C. difficile infections.

Based on the National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination, new 2020 national reduction targets are being established for C. difficile, and all hospitals participating in the Centers for Medicare & Medicaid Services' (CMS) Hospital Inpatient Quality Reporting Program have been reporting C. difficile infection data to CDC's National Healthcare Safety Network since 2013.

The data reported are from 2011 and represent the largest, longitudinal, US population-based surveillance for C. difficile infection to date, including laboratory-based surveillance across diverse US geographic locations.

[Source: CDC]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
APR 24, 2020
Genetics & Genomics
APR 24, 2020
Using Wastewater to Identify COVID-19 Hotspots
The SARS-CoV-2 pandemic is now known to have infected over 2.7 million individuals and killed at least 194,000.
APR 29, 2020
Genetics & Genomics
APR 29, 2020
Toxoplasma Infections Can Cause Epigenetic Changes in Males
Anywhere from 25 to 80% of the world's population is infected with a parasite called Toxoplasma gondii.
MAY 12, 2020
Chemistry & Physics
MAY 12, 2020
Improvised Face Covering: Finding Alternatives to Standard Masks During a Pandemic
On April 3rd, the US Centers for Disease Control and Prevention announced that they recommend members of the general pub ...
MAY 22, 2020
Health & Medicine
MAY 22, 2020
Smart Speakers can Identify Cardiac Arrest
Smart devices can control your lights, make your grocery list, and play songs on command. Researchers are now developing ...
MAY 24, 2020
Microbiology
MAY 24, 2020
Cavity-Causing Microbes Are Protected by Rings of Sugars and Germs
Bacteria can form tough communities called biofilms, which are difficult to remove and can resist the effects of antimic ...
Loading Comments...